{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs",
    "url": "https://www.lexblog.com/2023/06/30/analysis-of-u-s-food-and-drug-administration-draft-guidance-on-clinical-trials-with-psychedelic-drugs/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RPKRRFME",
        "url": "https://www.lexblog.com/lib/RPKRRFME/"
    },
    "datePublished": "2023-06-30T11:55:08-04:00",
    "dateModified": "2023-06-30T09:56:21-04:00",
    "author": {
        "@type": "Person",
        "name": "Paula Pastuskovas, Former Attorney Seth Mailhot, Kimberly Chew"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Husch Blackwell LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Insights",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://www.healthcarelawinsights.com/?p=5578",
    "sourceStability": "may-move"
}